MYCN and retinoblastoma: Further, to investigate the effects of MYCN inhibitors on untransformed cells, we treated retinal pigment epithelial cells (ARPE-19) with concentrations of each drug effective against RB cells and found that MYCN inhibition did not significantly change the viability of ARPE-19 cells (Figure S1).